FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 44 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $398,896 | -18.1% | 1,015,004 | 0.0% | 0.00% | – |
| Q4 2022 | $487,202 | -71.1% | 1,015,004 | +0.5% | 0.00% | – |
| Q3 2022 | $1,686,000 | -41.2% | 1,010,134 | 0.0% | 0.00% | – |
| Q2 2022 | $2,868,000 | -28.2% | 1,010,134 | +27.2% | 0.00% | – |
| Q1 2022 | $3,994,000 | -49.7% | 794,299 | -0.3% | 0.00% | – |
| Q4 2021 | $7,946,000 | +245.3% | 796,948 | +350.4% | 0.00% | – |
| Q3 2021 | $2,301,000 | -6.4% | 176,929 | +1.2% | 0.00% | – |
| Q2 2021 | $2,459,000 | +335.2% | 174,795 | +399.4% | 0.00% | – |
| Q1 2021 | $565,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 55,445 | $472,946 | 1.27% |